| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
JNJ 20788560 manufacturers
- JNJ-20788560
-
- $210.00
-
2026-05-06
- CAS:825649-28-3
- Purity: 98.77%
- Supply Ability: 10g
|
| | JNJ 20788560 Basic information |
| Product Name: | JNJ 20788560 | | Synonyms: | JNJ 20788560;9-(8-azabicyclo[3.2.1]octan-3-ylidene)-N,N-diethyl-9H-xanthene-3-carboxamide;9-(8-azabicyclo[3.2.1]octan-3-ylidene)-N,N-diethylxanthene-3-carboxamide;JNJ 20788560,JNJ20788560;9H-Xanthene-3-carboxamide, 9-(8-azabicyclo[3.2.1]oct-3-ylidene)-N,N-diethyl-;JNJ-20788560, 10 mM in DMSO | | CAS: | 825649-28-3 | | MF: | C25H28N2O2 | | MW: | 388.5 | | EINECS: | | | Product Categories: | | | Mol File: | 825649-28-3.mol |  |
| | JNJ 20788560 Chemical Properties |
| Boiling point | 567.8±50.0 °C(Predicted) | | density | 1.186±0.06 g/cm3(Predicted) | | pka | 10.58±0.20(Predicted) | | form | Solid | | color | Off-white to light yellow |
| | JNJ 20788560 Usage And Synthesis |
| Uses | JNJ-20788560 is a selective and orally active delta opioid receptor agonist with an affinity of 2.0 nM for DOR (rat brain cortex binding assay). JNJ-20788560 also is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence. JNJ-20788560 can be used for the research of the relief of inflammatory hyperalgesia[1]. | | References | [1] Codd EE, et al. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence. J Pharmacol Exp Ther. 2009 Apr;329(1):241-51. DOI:10.1124/jpet.108.146969 |
| | JNJ 20788560 Preparation Products And Raw materials |
|